Signaturefd LLC increased its stake in Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) by 125.5% in the 1st quarter, Holdings Channel.com reports. The company held 5,674 shares of the real estate investment trust after purchasing an additional 3,158 shares during the quarter. Signaturefd LLC’s holdings in Sabra Health Care REIT were worth $84,000 when it last filed with the SEC.
Other large investors have also recently changed their holdings in the company. Wedbush Securities Inc. bought a new stock position in Sabra Health Care REIT in Q1 for a value of approximately $740,000. Comerica Bank raised its position in Sabra Health Care REIT by 7.8% in the 1st quarter. Comerica Bank now owns 280,321 shares of the real estate investment trust worth $3,509,000 after buying an additional 20,295 shares in the last quarter. Bank of America Corp DE increased its position in Sabra Health Care REIT by 40.6% in the fourth quarter. Bank of America Corp DE now owns 335,561 shares of the real estate investment trust worth $4,543,000 after buying an additional 96,846 shares in the last quarter. Parallel Advisors LLC increased its position in Sabra Health Care REIT by 255.1% in Q1. Parallel Advisors LLC now owns 10,181 shares of the real estate investment trust worth $152,000 after buying an additional 7,314 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D increased its position in Sabra Health Care REIT by 10.3% in the fourth quarter. New Jersey State Joint Pension Fund D now owns 298,512 shares of the real estate investment trust worth $4,042,000 after purchasing an additional 27,980 shares in the last quarter. Hedge funds and other institutional investors own 91.61% of the company’s shares.
Sabra Health Care REIT trades up 0.5%
Shares of NASDAQ: SBRA opened at $15.08 on Thursday. The stock has a 50-day moving average of $14.07 and a 200-day moving average of $13.63. The company has a market capitalization of $3.48 billion, a PE ratio of -30.77 and a beta of 1.33. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt ratio of 0.70. Sabra Health Care REIT, Inc. has a 12-month low of $11.44 and a 12-month high of $19.01.
Sabra Healthcare REIT (NASDAQ: SBRA – Get a rating) last reported quarterly earnings data on Wednesday, May 4. The real estate investment trust reported earnings per share (EPS) of $0.18 for the quarter, beating consensus analyst estimates of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. In the same quarter a year earlier, the company posted earnings per share of $0.39. As a group, equity research analysts expect Sabra Health Care REIT, Inc. to post EPS of 1.47 for the current year.
Sabra Health Care REIT announces dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 31. Shareholders of record on Monday, May 16 received a dividend of $0.30. The ex-dividend date was Friday, May 13. This represents an annualized dividend of $1.20 and a yield of 7.96%. Sabra Health Care REIT’s payout ratio is -244.89%.
Analysts set new price targets
SBRA has been the subject of a number of recent analyst reports. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered its target price for the stock from $16.00 to $15.00 in a Wednesday, May 25 research report. Credit Suisse Group raised its price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a Monday, April 4 research report. StockNews.com began covering Sabra Health Care REIT in a research report on Thursday, March 31. They issued a “maintaining” rating for the company. Barclays downgraded shares of Sabra Health Care REIT from an “overweight” rating to an “equal weight” rating and cut its price target for the company from $16.00 to $14.00 in a research report from the Monday April 18. Finally, Capital One Financial began covering shares of Sabra Health Care REIT in a research report on Friday, June 3. They set an “equal weight” rating and a price target of $15.50 for the company. Seven investment analysts gave the stock a hold rating and five gave the stock a buy rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.85.
Sabra Health Care REIT Company Profile
As of March 31, 2022, Sabra’s investment portfolio included 416 properties held for investment. These include (i) 279 skilled nursing/transitional care facilities, (ii) 59 senior housing communities (senior residences – leased), (iii) 50 senior housing communities operated by third-party property managers pursuant to property management agreements (retirement homes – managed), (iv) 13 behavioral health facilities and (v) 15 specialty hospitals and other facilities), an asset held for sale, an investment in a lease-purchase, 16 investments in loans receivable (including (i) two mortgage loans, (ii) a construction loan and (iii) 13 other loans), seven investments in preferred shares and an investment in a unconsolidated joint venture.
Get news and reviews for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s free daily email newsletter.